This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Wyeth. Active years: 2009-2013.
Location History:
- Broomall, PA (US) (2009)
- Champaign, IL (US) (2013)
Company Filing History:
Years Active: 2009-2013
Title: Kelly Keating: Innovator in Synthetic Metabolites
Introduction
Kelly Keating is a prominent inventor based in Champaign, IL (US). She has made significant contributions to the field of synthetic metabolites, particularly through her innovative research and development efforts. With a total of 2 patents, her work has garnered attention in the scientific community.
Latest Patents
Kelly's latest patents include groundbreaking methods for generating synthetic metabolites of tanaproget derivatives. These patents detail the compounds and methods used for detecting tanaproget metabolites in various samples. Her research provides valuable insights into the applications of these derivatives, showcasing her expertise in the field.
Career Highlights
Kelly Keating is currently employed at Wyeth, where she continues to advance her research in synthetic metabolites. Her work at Wyeth has allowed her to collaborate with other talented professionals in the industry, further enhancing her contributions to the field.
Collaborations
Some of Kelly's notable coworkers include Oliver McConnell and Appavu Chandrasekaran. Their collaborative efforts have played a crucial role in the development of innovative solutions in their research endeavors.
Conclusion
In summary, Kelly Keating is a distinguished inventor whose work in synthetic metabolites has made a significant impact. Her patents and research continue to influence the scientific community, highlighting her role as a leading innovator in her field.